|
1
|
Surabhi VR, Chua S, Patel RP, Takahashi N,
Lalwani N and Prasad SR: Inflammatory myofibroblastic tumors:
Current update. Radiol Clin North Am. 54:553–563. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Griffin CA, Hawkins AL, Dvorak C, Henkle
C, Ellingham T and Perlman EJ: Recurrent involvement of 2p23 in
inflammatory myofibroblastic tumors. Cancer Res. 59:2776–2780.
1999.PubMed/NCBI
|
|
3
|
Lawrence B, PerezAtayde A, Hibbard MK,
Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiao S, Yi ES, Fletcher
CD and Fletcher JA: TPM3-ALK and TPM4-ALK oncogenes in inflammatory
myofibroblastic tumors. Am J Pathol. 157:377–384. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coffin CM, Patel A, Perkins S,
ElenitobaJohnson KS, Perlman E and Griffin CA: ALK1 and p80
expression and chromosomal rearrangements involving 2p23 in
inflammatory myofibroblastic tumor. Mod Pathol. 14:569–576. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Antonescu CR, Suurmeijer AJ, Zhang L, Sung
YS, Jungbluth AA, Travis WD, AlAhmadie H, Fletcher CD and Alaggio
R: Molecular characterization of inflammatory myofibroblastic
tumors with frequent ALK and ROS1 fusions and rare novel RET
rearrangement. Am J Surg Pathol. 39:957–967. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Butrynski JE, D'Adamo DR, Hornick JL, Dal
Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ,
Ramaiya N, et al: Crizotinib in ALK-rearranged inflammatory
myofibroblastic tumor. N Engl J Med. 363:1727–1733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mano H: ALKoma: A cancer subtype with a
shared target. Cancer Discov. 2:495–502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanders H, Li H, Bruey JM, Scheerle JA,
MeloniEhrig AM, Kelly JC, Novick C and Albitar M: Exon scanning by
reverse transcriptase polymerase chain reaction for detection of
known and novel EML4-ALK fusion variants in non-small cell lung
cancer. Cancer Genet. 204:45–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fletcher C, Bridge JA, Hogendoorn PC, et
al: WHO Classification of Tumours of Soft Tissue and Bone. IARC;
Lyon: 2013
|
|
10
|
Graefe H, Stellmacher F, Sotlar K,
Wollenberg B and Gehrking E: Inflammatory pseudotumor of the
hypopharynx: Clinical diagnosis, immunohistochemical findings and
treatment of this rare disease. In Vivo. 22:817–820.
2008.PubMed/NCBI
|
|
11
|
Nakayama K, Inoue Y, Aiba T, Kono K,
Wakasa K and Yamada R: Unusual CT and MR findings of inflammatory
pseudotumor in the parapharyngeal space: Case report. AJNR Am J
Neuroradiol. 22:1394–1397. 2001.PubMed/NCBI
|
|
12
|
Lovly CM, Gupta A, Lipson D, Otto G,
Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA
and Coffin CM: Inflammatory myofibroblastic tumors harbor multiple
potentially actionable kinase fusions. Cancer Discov. 4:889–895.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cook JR, Dehner LP, Collins MH, Ma Z,
Morris SW, Coffin CM and Hill DA: Anaplastic lymphoma kinase (ALK)
expression in the inflammatory myofibroblastic tumor: A comparative
immunohistochemical study. Am J Surg Pathol. 25:1364–1371. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ni C, Xu YY, Zhou SH and Wang SQ:
Differential diagnosis of inflammatory myofibroblastic tumour and
low-grade myofibroblastic sarcoma: Two case reports with a
literature review. J Intern Med Res. 39:311–320. 2011. View Article : Google Scholar
|
|
15
|
Soda M, Choi YL, Enomoto M, Takada S,
Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K,
Hatanaka H, et al: Identification of the transforming EML4-ALK
fusion gene in non-small-cell lung cancer. Nature. 448:561–566.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bridge JA, Kanamori M, Ma Z, Pickering D,
Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M
and Morris SW: Fusion of the ALK gene to the clathrin heavy chain
gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol.
159:411–415. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cools J, Wlodarska I, Somers R, Mentens N,
Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A and
Marynen P: Identification of novel fusion partners of ALK, the
anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and
inflammatory myofibroblastic tumor. Genes Chromosomes Cancer.
34:354–362. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma Z, Hill DA, Collins MH, Morris SW,
Sumegi J, Zhou M, Zuppan C and Bridge JA: Fusion of ALK to the
Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic
tumor. Genes Chromosomes Cancer. 37:98–1053. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Debiec-Rychter M, Marynen P, Hagemeijer A
and Pauwels P: ALK-ATIC fusion in urinary bladder inflammatory
myofibroblastic tumor. Genes Chromosomes Cancer. 38:187–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Panagopoulos I, Nilsson T, Domanski HA,
Isaksson M, Lindblom P, Mertens F and Mandahl N: Fusion of the
SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int
J Cancer. 118:1181–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takeuchi K, Soda M, Togashi Y, Sugawara E,
Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H and Ishikawa Y:
Pulmonary inflammatory myofibroblastic tumor expressing a novel
fusion, PPFIBP1-ALK: Reappraisal of anti-ALK immunohistochemistry
as a tool for novel ALK fusion identification. Clin Cancer Res.
17:3341–3381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Krishnan C, Nguyen EP, Meyer KJ,
Oliveira JL, Yang P, Yi ES, EricksonJohnson MR, Yaszemski MJ, Maran
A and Oliveira AM: Fusion of dynactin 1 to anaplastic lymphoma
kinase in inflammatory myofibroblastic tumor. Hum Pathol.
43:2047–2052. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mariño-Enríquez A, Wang WL, Roy A,
LopezTerrada D, Lazar AJ, Fletcher CD, Coffin CM and Hornick JL:
Inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal
variant of inflammatory myofibroblastic tumor with nuclear membrane
or perinuclear ALK. Am J Surg Pathol. 35:135–144. 2011. View Article : Google Scholar : PubMed/NCBI
|
